These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24236554)

  • 21. Building sustainable multi-functional prospective electronic clinical data systems.
    Randhawa GS; Slutsky JR
    Med Care; 2012 Jul; 50 Suppl():S3-6. PubMed ID: 22692255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness research priorities: identifying critical gaps in evidence for clinical and health policy decision making.
    Chalkidou K; Whicher D; Kary W; Tunis S
    Int J Technol Assess Health Care; 2009 Jul; 25(3):241-8. PubMed ID: 19619341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does comparative effectiveness research promote rationing of cancer care?
    Peppercorn J; Zafar SY; Houck K; Ubel P; Meropol NJ
    Lancet Oncol; 2014 Mar; 15(3):e132-8. PubMed ID: 24534292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management options for children with attention-deficit/hyperactivity disorder: a regional perspective on value.
    Ollendorf DA; Migliaccio-Walle K; Colby JA; Pearson SD
    J Comp Eff Res; 2013 May; 2(3):261-71. PubMed ID: 24236625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods for engaging stakeholders in comparative effectiveness research: a patient-centered approach to improving diabetes care.
    Schmittdiel JA; Desai J; Schroeder EB; Paolino AR; Nichols GA; Lawrence JM; O'Connor PJ; Ohnsorg KA; Newton KM; Steiner JF
    Healthc (Amst); 2015 Jun; 3(2):80-8. PubMed ID: 26179728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A practice-based tool for engaging stakeholders in future research: a synthesis of current practices.
    Guise JM; O'Haire C; McPheeters M; Most C; Labrant L; Lee K; Barth Cottrell EK; Graham E
    J Clin Epidemiol; 2013 Jun; 66(6):666-74. PubMed ID: 23497857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engaging Stakeholders to Develop a Patient-centered Research Agenda: Lessons Learned From the Research Action for Health Network (REACHnet).
    Haynes SC; Rudov L; Nauman E; Hendryx L; Angove RSM; Carton T
    Med Care; 2018 Oct; 56 Suppl 10 Suppl 1(10 Suppl 1):S27-S32. PubMed ID: 30074948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stakeholder assessment of comparative effectiveness research needs for Medicaid populations.
    Fischer MA; Allen-Coleman C; Farrell SF; Schneeweiss S
    J Comp Eff Res; 2015 Sep; 4(5):465-71. PubMed ID: 26388438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness research in the U.S.A.: when will there be an impact on healthcare decision-making?
    Westrich KD; Wilhelm JA; Schur CL
    J Comp Eff Res; 2016 Mar; 5(2):207-16. PubMed ID: 26844982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effectiveness research in the United States: a progress report.
    Sullivan SD; Carlson JJ; Hansen RN
    J Med Econ; 2013; 16(2):295-7. PubMed ID: 23227997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approaches to comparative effectiveness research in multimorbid populations.
    Maciejewski ML; Bayliss EA
    Med Care; 2014 Mar; 52 Suppl 3():S23-30. PubMed ID: 24561754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priority setting and the ethics of resource allocation within VA healthcare facilities: results of a survey.
    Foglia MB; Pearlman RA; Bottrell MM; Altemose JA; Fox E
    Organ Ethic; 2008; 4(2):83-96. PubMed ID: 18839751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating patient and stakeholder engagement in research: moving from theory to practice.
    Esmail L; Moore E; Rein A
    J Comp Eff Res; 2015 Mar; 4(2):133-45. PubMed ID: 25825842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translating tuberculosis research into global policies: the example of an international collaboration on diagnostics.
    Ramsay A; Steingart KR; Cunningham J; Pai M
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1283-93. PubMed ID: 22283885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prioritization in comparative effectiveness research: the CANCERGEN Experience.
    Thariani R; Wong W; Carlson JJ; Garrison L; Ramsey S; Deverka PA; Esmail L; Rangarao S; Hoban CJ; Baker LH; Veenstra DL;
    Med Care; 2012 May; 50(5):388-93. PubMed ID: 22274803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging perspectives on transforming the healthcare system: redesign strategies and a call for needed research.
    Doebbeling BN; Flanagan ME
    Med Care; 2011 Dec; 49 Suppl():S59-64. PubMed ID: 22095034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.
    Trosman JR; Weldon CB; Schink JC; Gradishar WJ; Benson AB
    J Comp Eff Res; 2013 Jul; 2(4):461-77. PubMed ID: 24236686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.
    Ahmed S; Berzon RA; Revicki DA; Lenderking WR; Moinpour CM; Basch E; Reeve BB; Wu AW;
    Med Care; 2012 Dec; 50(12):1060-70. PubMed ID: 22922434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matching study designs to disability-related comparative effectiveness research questions.
    Ballou J; Rich E; Kehn M
    J Comp Eff Res; 2013 Jan; 2(1):59-68. PubMed ID: 24236522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.